For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Immunisation coverage – good gains over recent decades, but recent slippage
+Practice
Child health
Immunisation coverage – good gains over recent decades, but recent slippage
Monday 8 April 2019, 09:00 AM

Access to healthcare is a key issue in improving vaccination rates
There are multiple determinants of the rates of immunisation coverage in New Zealand, and the response for improving rates needs to be multipronged and sometimes targeted and tailored to the specific concerns of local communities
Overall, New Zealand has done really well with immunisation coverage rates for our children. Back in the early 1990s, barely more than 50 per cent of
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.